NYSE:HIMS Hims & Hers Health (HIMS) Stock Price, News & Analysis $14.57 -1.45 (-9.05%) Closing price 11/20/2026 03:59 PM EasternExtended Trading$15.10 +0.53 (+3.64%) As of 11/20/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Hims & Hers Health Stock (NYSE:HIMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Hims & Hers Health alerts:Sign Up Key Stats Today's Range$14.51▼$15.9650-Day Range$14.57▼$30.8752-Week Range$13.74▼$40.99Volume16.06 million shsAverage Volume15.96 million shsMarket Capitalization$3.42 billionP/E RatioN/ADividend YieldN/APrice Target$30.80Consensus RatingHold Company Overview Hims & Hers Health, Inc. operates a consumer-focused telehealth platform that connects patients with licensed healthcare providers and offers access to treatments and wellness products. Its services include online consultations, prescription care and over-the-counter products. The company serves a range of health needs, including hair loss, sexual health, skin care, mental health and weight management. Its platform also offers primary care and other services, with offerings varying by location and individual eligibility. Founded in 2017, the company initially launched its Hims brand and later introduced Hers, expanding its services to a broader audience. Co-founder Andrew Dudum serves as chief executive officer. Hims & Hers is based in the United States and has expanded into select international markets.AI Generated. May Contain Errors. Read More Hims & Hers Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreHIMS MarketRank™: 2.565900168255 of 5 starsHims & Hers Health scored higher than 51% of companies evaluated by MarketBeat, and ranked 464th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingHims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on no strong buy ratings, 3 buy ratings, 12 hold ratings, and 1 sell rating.Upside PotentialHims & Hers Health has a consensus price target of $30.80, representing about 111.4% upside from its current price of $14.57.Amount of Analyst CoverageHims & Hers Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Hims & Hers Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Hims & Hers Health are expected to grow in the coming year, from ($0.38) to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hims & Hers Health is -17.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hims & Hers Health is -17.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHims & Hers Health has a P/B Ratio of 9.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted25.09% of the float of Hims & Hers Health has been sold short.Short Interest Ratio / Days to CoverHims & Hers Health has a short interest ratio ("days to cover") of 5.84.Change versus previous monthShort interest in Hims & Hers Health has recently decreased by 3.40%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHims & Hers Health does not currently pay a dividend.Dividend GrowthHims & Hers Health does not have a long track record of dividend growth. News and Social Media1.2 / 5News Sentiment-0.01 News SentimentHims & Hers Health has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Hims & Hers Health this week, compared to 8 articles on an average week.Search InterestOnly 43 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -27% compared to the previous 30 days.MarketBeat FollowsOnly 11 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -21% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,764,840.00 in company stock.Percentage Held by Insiders11.76% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Hims & Hers Health's insider trading history. Receive HIMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HIMS Stock News HeadlinesBank of America Issues Pessimistic Forecast for Hims & Hers Health (NYSE:HIMS) Stock PriceNovember 22 at 2:18 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Cut to Sell at Wall Street ZenNovember 21 at 1:30 AM | americanbankingnews.comUnder 3 cents a nightBill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.November 22 at 1:00 AM | Profits Run (Ad)Hims & Hers Health (HIMS) Stock Looks Discounted Even As Risks Stay In FocusNovember 20 at 12:26 PM | finance.yahoo.comHims & Hers Health (HIMS) Launches Peptides+ Longevity Platform Across The U.S.November 20 at 12:26 PM | finance.yahoo.comHims & Hers Health (NYSE:HIMS) Stock: Insider Oluyemi Okupe Sells 3,518 SharesNovember 19 at 7:22 AM | insidertrades.comHims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffHims & Hers stock sank after a Q3 earnings and revenue miss, lower EBITDA guidance, subscriber declines, and an expanding FTC lawsuit over privacy and billing practices.November 12, 2026 | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock: Insider Soleil Boughton Sells 3,462 SharesOctober 30, 2026 | insidertrades.comSee More Headlines HIMS Stock Analysis - Frequently Asked Questions How have HIMS shares performed this year? Hims & Hers Health's stock was trading at $32.45 on January 1st, 2026. Since then, HIMS shares have decreased by 55.1% and is now trading at $14.57. How were Hims & Hers Health's earnings last quarter? Hims & Hers Health, Inc. (NYSE:HIMS) announced its earnings results on Monday, November, 9th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.06 by $0.03. The firm's revenue for the quarter was up 48.6% on a year-over-year basis. Read the conference call transcript. Is Hims & Hers Health doing a stock buyback? Hims & Hers Health's board approved a stock buyback program on Monday, November 17th 2025, which permits the company to repurchase $250 million in outstanding shares, according to EventVestor. This means that the company could purchase up to 3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board believes its shares are undervalued. Who are Hims & Hers Health's major shareholders? Top institutional shareholders of Hims & Hers Health include State Street Corp (3.53%), Greenfield Seitz Capital Management LLC (0.17%), Commonwealth Equity Services LLC (0.12%) and First Trust Advisors LP (0.10%). Insiders that own company stock include Melissa Baird, Michael Chi, Soleil Boughton, Oluyemi Okupe, David B Wells, Patrick Harrison Carroll, Christopher D Payne, Andrew Dudum, Garcia Andrea G Perez, Deborah M Autor, Christiane Pendarvis, Irene Becklund, Irene Becklund, Anja Manuel and Lynne Chou O'keefe. View institutional ownership trends. How do I buy shares of Hims & Hers Health? Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Hims & Hers Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Tesla (TSLA), SoFi Technologies (SOFI), Super Micro Computer (SMCI) and Micron Technology (MU). Company Calendar Last Earnings11/09/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 13 days, HIMS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:HIMS CIK1773751 Webwww.forhims.com Phone415-851-0195FaxN/AEmployees2,442Year Founded2017Price Target and Rating Average Price Target for Hims & Hers Health$30.80 High Price Target$60.00 Low Price Target$21.00 Potential Upside/Downside+111.4%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.83) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$128.37 million Net Margins-6.65% Pretax Margin-7.74% Return on Equity-9.62% Return on Assets-1.38% Debt Debt-to-Equity Ratio3.85 Current Ratio0.92 Quick Ratio0.84 Sales & Book Value Annual Sales$2.87 billion Price / Sales1.19 Cash Flow$0.83 per share Price / Cash Flow17.45 Book Value$1.52 per share Price / Book9.59Miscellaneous Outstanding Shares234,412,000Free Float206,845,000Market Cap$3.42 billion OptionableOptionable Beta2.53 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:HIMS) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredGold Miners Post Record Cash Flows as AI Stocks WobbleGold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.